cbdMD issues $1.7 million in Series B preferred stock to institutional investors
PositiveFinancial Markets

cbdMD has successfully issued $1.7 million in Series B preferred stock to institutional investors, marking a significant step in their capital-raising efforts. This move not only strengthens their financial position but also reflects growing confidence from investors in the company's potential. Such investments are crucial for cbdMD as they aim to expand their operations and enhance product offerings in the competitive CBD market.
— Curated by the World Pulse Now AI Editorial System